http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013086162-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59a64c96b008aa6505548acb3cc0fa68 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0202 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-50 |
| filingDate | 2012-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adc6ab16e5e4374fe18fe53cd87bb1fd |
| publicationDate | 2013-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2013086162-A1 |
| titleOfInvention | Radioiodinateable angiotensin-converting enyzyme-2 (ace-2) modulating compounds, preparation thereof, and methods for use thereof |
| abstract | The invention provides angiotensin-converting enzyme-2 (ACE-2) inhibitors and radioligands for measuring ACE-2 protein (quantifying amounts of protein), for determining tissue distribution of ACE-2 protein, and/or for measuring experimentally-induced changes in ACE-2 protein expression. The invention also provides pharmaceutical compositions containing the ACE-2 inhibitors and radioligands, processes and intermediates for preparing the ACE-2 inhibitors and radioligands, methods of using the ACE-2 inhibitors and radioligands for modulating the activity of angiotensin-converting enzyme-2 (ACE-2) protein, and methods of using the ACE-2 inhibitors and radioligands for treating ACE-2 associated conditions. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022056115-A1 |
| priorityDate | 2011-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.